Saturday, November 23, 2024
HomeTagsRisankizumab

risankizumab

AbbVie Announces European Commission Approval of SKYRIZI for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics